drugset / Trial / NCT00498784

HR-QoL and Sexuality in Mirena Inserted Contraception Users

NCT00498784

Phase 4 Completed 141 enrolled Bayer
Non-randomizedSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to evaluate the changes in the quality of life, as well as in the sexual activity, in women inserted with MIRENA, a hormonal contraceptive intra-uterine system, over the first 12 months of use. Patients switching from oral contraception to an intrauterine contraceptive device (here: MIRENA) will be observed in the first year post MIRENA insertion.

Timeline

Start
2005-11
Primary completion
2007-10
Completion
2007-10

Drugs

EvaluationDrugModalityDoseRoute
Background Levonorgestrel Small molecule 52 mg Other

Indications

No indication recorded.